Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,457,205
-$46,318 QoQ
Shares Held
11,534
+6.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#937
of 2,266 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verde Capital Management holds $1,745,714 across 2 Drug Manufacturers - General names. GILD ranks #1 (83.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
This page
|
11,534 | $1,457,205 | |
| 2 | JNJ |
Johnson & Johnson
|
1,136 | $288,509 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,457,205 | 11,534 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,503,523 | 10,788 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,244,092 | 10,136 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,097,901 | 9,891 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||